Evidence map›Paper›PMID 40308614›Full record

ReviewFrontiers in immunology2025

Neural stem cell-derived small extracellular vesicles: a new therapy approach in neurological diseases.

Mengyao Wang, Dongdong Chen, Renjie Pan, Yue Sun, Xinyu He, Youming Qiu, Yuexin Hu, Xiangsheng Wu, Xuxiang Xi, Rong Hu and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mengyao Wang *Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Dongdong Chen *Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Renjie PanDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Yue SunDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Xinyu HeDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Youming QiuDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Yuexin HuDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Xiangsheng WuDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Xuxiang XiDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Rong HuDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Zhigang JiaoDepartment of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural stem cells (NSCs) possess pluripotent characteristics, proliferative capacity, and the ability to self-renew. In the context of neurological diseases, transplantation of NSCs has been shown to facilitate neurological repair through paracrine mechanisms. NSC-derived small extracellular vesicles (NSC-sEVs), a prominent component of the NSC secretome, play a crucial role in modulating various physiological and pathological processes, such as regulating the NSC microenvironment, promoting endogenous NSC differentiation, and facilitating the maturation of neurons and glial cells. Moreover, NSC-sEVs exhibit reduced immunogenicity, decreased tumorigenic potential, and enhanced ability to traverse the blood-brain barrier. Consequently, NSC-sEVs present novel therapeutic approaches as non-cellular treatments for neurological disorders and are poised to serve as a viable alternative to stem cell therapies. Furthermore, NSC-sEVs can be manipulated to enhance production efficiency, improve biological activity, and optimize targeting specificity, thereby significantly advancing the utilization of NSC-sEVs in clinical settings for neurological conditions. This review provides a comprehensive overview of the biological functions of NSC-sEVs, their therapeutic implications and underlying molecular mechanisms in diverse neurological disorders, as well as the potential for engineering NSC-sEVs as drug delivery platforms. Additionally, the limitations and challenges faced by NSC-sEVs in practical applications were discussed in depth, and targeted solutions were proposed.

Indexed as

Extracellular VesiclesNervous System DiseasesNeural Stem CellsAnimalsCell DifferentiationHumansneural stem cellneurological diseasesneuroprotectiveNSC-derived small extracellular vesiclessmall extracellular vesicles

Identifiers

PMID40308614
PMCPMC12040699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.